{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:18:22Z","timestamp":1791303502687,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":4840,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1111\/j.1600-6143.2009.02668.x","type":"journal-article","created":{"date-parts":[[2009,5,20]],"date-time":"2009-05-20T09:52:00Z","timestamp":1242813120000},"page":"1607-1619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial"],"prefix":"10.1016","volume":"9","author":[{"given":"R.S.","family":"Gaston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cibrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mulgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-U.","family":"Meier-Kriesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl","key":"10.1111\/j.1600-6143.2009.02668.x_bib1","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1097\/01.tp.0000186386.13597.cb","article-title":"Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation","volume":"80","author":"Land","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ncpneph0225","article-title":"Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts","volume":"2","author":"Liptak","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib4","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00007890-200210270-00002","article-title":"Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporine","volume":"74","author":"Flechner","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1600-6143.2004.00404.x","article-title":"Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy","volume":"4","author":"Suwelack","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ftd.0000199358.80013.bd","article-title":"Therapeutic drug monitoring of mycophenolate mofetil in transplantation","volume":"28","author":"Van Gelder","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib7","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1600-6143.2004.00533.x","article-title":"Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil","volume":"4","author":"Merville","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0041-1345(01)02788-9","article-title":"Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation: A Spanish multicenter study","volume":"34","author":"Gonzalez Molina","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib9","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-6143.2006.01633.x","article-title":"Mycophenolate mofetil is associated with altered expression of chronic renal transplant histology","volume":"7","author":"Nankivell","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Renal Transplant Mycophenolate Mofetil Study Group.Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients.","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"European Mycophenolate Mofetil Cooperative Study Group.Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib14","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"2 Supply","key":"10.1111\/j.1600-6143.2009.02668.x_bib15","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/01.tp.0000186380.61251.fc","article-title":"The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation","volume":"80","author":"Van Gelder","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/01.tp.0000276936.14041.6c","article-title":"The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide","volume":"84","author":"Naesens","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","article-title":"The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation","volume":"64","author":"Hale","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007890-199907270-00018","article-title":"A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation","volume":"68","author":"Van Gelder","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1053-2498(00)00191-1","article-title":"Mycophenolic acid concentrations are associated with cardiac allograft rejection","volume":"19","author":"DeNofrio","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00007691-200002000-00004","article-title":"German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring.","volume":"22","author":"Oellerich","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.V133759","article-title":"The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: A report of the German Study Group on Mycophenolate Mofetil Therapy","volume":"13","author":"Weber","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1053\/j.ackd.2006.04.008","article-title":"Infectious complications in renal transplant recipients","volume":"13","author":"Parasuraman","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2 Suppl","key":"10.1111\/j.1600-6143.2009.02668.x_bib23","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib24","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2007.01983.x","article-title":"Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation","volume":"7","author":"Le Meur","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0b013e318186f98a","article-title":"Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: The Fixed-Dose Concentration-Controlled Trial","volume":"86","author":"Van Gelder","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00007691-200010000-00008","article-title":"Evaluation of limited sampling strategies for estimation of 12-hour mycophenolic acid area under the plasma concentration-time curve in adult renal transplant patients","volume":"22","author":"Willis","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00228-001-0389-2","article-title":"Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy","volume":"57","author":"Le Guellec","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007691-200202000-00012","article-title":"Monitoring of mycophenolic acid in clinical transplantation","volume":"24","author":"Shaw","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib29","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/clinchem\/48.9.1497","article-title":"Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus","volume":"48","author":"Pawinski","year":"2002","journal-title":"Clin Chem"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib30","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199506270-00007","article-title":"Predicting glomerular filtration rate after kidney transplantation","volume":"59","author":"Nankivell","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02668.x_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.ftd.0000152682.13647.5e","article-title":"Influence of cyclosporine on the serum concentration and biliary excretion of mycophenolic acid and 7-O-mycophenolic acid glucuronide","volume":"27","author":"Deters","year":"2005","journal-title":"Ther Drug Monit"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2009.02668.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522017348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522017348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2009.02668.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:47:58Z","timestamp":1761626878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522017348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1600613522017348"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02668.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02668.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}